Endo International is poised to receive increasing attention from the market as relevant events are taking place. The Irish-domiciled generics and specialty branded pharmaceutical company has been involved in the US lawsuits against opioid makers this year and has exposure to ongoing developments in these cases and could diminish attempt to rebound.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.